Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
16
self-reported 11–50 band
Founded
Not recorded
Legal entities
1
ABR
Office countries
2
2 addresses
Funding rounds
3
Series B · Feb 2024 · US$ 22.2M
Company type
Privately Held
self-reported
Legal entity
1 brand → 1 confirmed entity
ARAVAX PTY LTD
ABN19602993475
Legal entities
Show as table · Aravax: 1 registry entity
| ARAVAX PTY LTD | ABN 19602993475 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
Aravax is a clinical stage biotechnology company dedicated to revolutionising the treatment of food allergy by developing next-generation, disease-modifying peptide-based immunotherapies that are safer and more convenient than existing approaches. Its lead programme is PVX108, in clinical development for the treatment of peanut allergy.
Locations
2
Countries with an office address2 addresses on record
AustraliaprimaryUnited Kingdom
Country footprint
Show as table · Offices in 2 countries
| Countries | 2 |
|---|---|
| Primary country | AU |
All codes: AU GB
Addresses
- GBJohn Eccles House, Oxford Science Park; Oxford, OX4 4GP
- AULevel 9, 31 Queens Street; Melbourne, Victoria 3000Primary
Grid intelligence Members
Funding
Last round · 23 February 2024US$ 22.2MSeries B
Rounds3
Round typeSeries B · venture round
Amount (USD)22,200,000
Stage rank4
Investors named0
Since last round1 yr 11 mo
Funding
Show as table · 3 funding rounds
| Rounds | 3 |
|---|---|
| Axis | 2024 to 2026 |
| Series B · 23 Feb 2024 | US$ 22.2M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
FAQ
Which legal entity operates under Aravax?
One Victoria entity on the ABR: ARAVAX PTY LTD (ABN 19 602 993 475), high confidence.
How many people work at Aravax?
16 counted staff profiles at January 2026, inside the self-reported 11–50 band.
Where does Aravax have offices?
Two addresses on record across 2 countries. Primary: Level 9, 31 Queens Street, Melbourne, Victoria 3000.
Has Aravax raised funding?
Three rounds. Latest 23 February 2024: Series B, US$22,200,000.
Which companies are listed alongside Aravax?
11 profiles list Aravax as a peer — 84th percentile in Biotechnology Research. It lists ten peers of its own. ENA Respiratory and Atmo Biosciences list it back.